A significant breakthrough in cancer study is occurring with the use of VHH fragments to reactivate damaged p53. This crucial tumor protector protein is frequently disabled in many types of malignancies, causing https://e-bookmarks.com/story7744134/mini-antibodies-reactivate-p53-new-new-approach-for-cancer-therapy